Source: Annual Congress 2009 - Pulmonary circulation II
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. A. Andreeva, M. A. Saidova, T. V. Martynyuk, V. P. Masenko, A. V. Volkov, I. Y. Chazova (Moscow, Russian Federation). Natriuretic peptides levels and heart remodeling in different forms of pulmonary hypertension. Eur Respir J 2009; 34: Suppl. 53, 3931

Member's Comments

No comment yet.

Related content which might interest you: Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007 N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 509-513 Year: 2005 Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010 Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 1286-1293 Year: 2010 Inhalation of vasoactive intestinal peptide in pulmonary hypertension Source: Eur Respir J 2008; 32: 1289-1294 Year: 2008 Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Biomarkers in pulmonary hypertension Source: Eur Respir J 2008; 32: 503-512 Year: 2008 N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management Year: 2006 Connection of traditional echocardiographic and tissue doppler imaging parameters and brain natriuretic peptide levels in patients with different forms of pulmonary hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Association of haemodynamic parameters with circulating natriuretic peptides in precapillary pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Patients with primary or thromboembolic pulmonary hypertension develop renal resistance to ANP and BNP Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Effects of erythropoietin on advanced pulmonary vascular remodelling Source: Eur Respir J 2008; 31: 126-134 Year: 2008 Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Effects of different pacing modes on vasoactive intestinal peptide levels in pacemaker patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 58s Year: 2001